glutathione gbm6 patient derived xenograft Frontiers Combined inhibition of de novo
Combined inhibition of de novo glutathione and nucleotide biosynthesis is synthetically lethal in glioblastoma: Cell Reports glutathione gbm6 patient derived xenograft Methionine cycle inhibition disrupts antioxidant metabolism and reduces glioblastoma cell survival Combined inhibition of de novo glutathione gbm6 patient derived xenograft Patientderived models in pancancer: From bench to clinic Li 2025 Interdisciplinary Medicine Patient derived Xenografts A Critical Combined inhibition of de novo glutathione and nucleotide biosynthesis is synthetically lethal in glioblastoma ScienceDirect
Pay in 4 interest-free payments of $5.29 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15



